Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction

This publication has 25 references indexed in Scilit:

• Prognostic Value of Hemodynamic vs Big Endothelin Measurements During Long-term IV Therapy in Advanced Heart Failure Patients
  Chest, 2000
• Value of cardiopulmonary exercise testing and big endothelin plasma levels to predict short-term prognosis of patients with chronic heart failure
  Journal of the American College of Cardiology, 1998
• Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
  American Heart Journal, 1998
• Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators
  Published by Oxford University Press (OUP) ,1997
• Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment
  Clinical Endocrinology, 1997
• Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure
  Circulation, 1997
• Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction
  The American Journal of Cardiology, 1996
• Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure
  Journal of the American College of Cardiology, 1996
• Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure
  The American Journal of Cardiology, 1995
• Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
  Circulation, 1994